Form 6-K SASOL LTD For: Feb 23
Tweet
Share
E-mail
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SASOL LIMITED - BUSINESS PERFORMANCE METRICS FOR THE YEAR ENDED 30 JUNE 2026
- Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026; Annual General Meeting Planned for End of September 2026
- Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
